IMDX Insight Molecular: Accounting Value per Share

Graphic logo of Insight Molecular Diagnostics (IMDX)

Insight Molecular Diagnostics is expanding its network of precision biomarker tests through laboratory partnerships, while utilizing external IT outsourcing and contract manufacturing for its systems. On GURU.Markets, the adjusted book value of the share demonstrates capital dynamics, where the value -0.65 captures the metric level. Meanwhile, limited pricing power due to insurance tariffs is forcing the company to increase its operational volumes.

Insight Molecular (IMDX) - Accounting Value per Share from 06/19/2025 to 10/27/2026

Summary analytical data breakdowns for Insight Molecular Diagnostics, Inc. (IMDX)

- price and consensus price forecast:
Stock Price Insight Molecular|IMDX - Broker Consensus Forecast
- market capitalization data:
Market Valuation Insight Molecular Diagnostics Inc|IMDX - Business Value
- book capitalization data:
Net Assets per Single Share Insight Molecular Diagnostics|IMDX - Company Net Assets|Market Capitalization to Book Value Ratio imdxinc.com|IMDX - Company Assets
- debt and liquidity data:
Total Debt to Capital Insight Molecular Diagnostics|IMDX - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Insight Molecular|IMDX - Company Aggregate Debts|Debt to Book Capitalization Ratio Insight Molecular Diagnostics Inc
Fundamental company valuation:Insight Molecular Diagnostics
Manufactured product of Insight Molecular Diagnostics, Inc.

Book value per share reflects the company's net capital after deducting all liabilities, determining the actual value of the owner's equity. By analyzing the book value per share visualization, an investor assesses the asset stability of Insight Molecular Diagnostics (IMDX), where the capitalization of innovative biomarkers and laboratory equipment for early diagnostics directly impacts the fundamental value of each share.

Competitors of Insight Molecular Diagnostics (IMDX)

Agilent Tech (A) - Book Value per Share|Quest Corp (DGX) - Equity per Share|Accounting Value per Share Illumina, Inc.|EXAS (exactsciences.com) - Equity per Share|Net Assets per Single Share RVTY|Accounting Value per Share Bio-Rad Laboratories, Inc.|Anbio Tech - Book Value per Share|Net Asset Value per Share Nordion (SHC)|QDEL - Book Value per Share|Equity per Share opko.com OPK|CareDx, Inc - Book Value per Share|MRVI: Book Value per Share|Net Assets per Single Share Fulgent Corp|Standard BioTools Corp (LAB) - Equity per Share|CTKB (Cytek Biosciences, Inc.) - Book Value per Share|Book Value per Share OSUR|Net Assets per Single Share Exagen Inc. (XGN)|Net Assets per Single Share MDxHealth S.A. MDXH|LUCD: Accounting Value per Share|Prenetics Global Limited - Net Asset Value per Share|Net Assets per Single Share TRIB (Trinity Biotech Corp)|PRPH - Net Assets per Share|Ainos - Book Value per Share|CODX (Co-Diagnostics Inc) - Net Assets per Share|HSCS: Net Assets per Single Share|Net Assets per Share Biomerica Inc|CDIO (Cardio Diagnostics) - Book Value per Share|Net Assets per Share VRAX (viraxbiolabs.com)|BJDX - Net Assets per Single Share|Aspira Women's Health, Inc. - Equity per Share|Net Assets per Single Share AXDX (Accelerate Diagnostics, Inc)|CNTG - Net Assets per Share|enzo.com - Book Value per Share|Fresh2 Group (FRES) - Net Assets per Share|Genetic Technologies Ltd - Book Value per Share|Book Value of One Share 23andMe Holding Co|Psychemedics Corp (PMD) - Book Value per Share